A shadow economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for supplier links, while also receiving discount codes.
Thriving Commerce on Social Networks
Additionally, a robust market exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and claims of rapid British shipping. Sellers market the drug there before redirecting customers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Voice Worries
However, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.
Some professionals said the popularity for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.
Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Service Response and Content Elimination
Based on the social media company, the platform has taken down problematic content and banned related hashtags and search suggestions. The company stated it was committed to keeping the service safe and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also discovered groups with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, positive testimonials and detailed guides for preparing or administering at residence.
Within moments of entering one community, a seller posted WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.
Item Information and Pricing
Within these communities, messages display dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting materials they cannot confirm. Although the research behind this drug is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has already encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially serious health risks”.
